Edwards Lifesciences Corp (NYSE:EW)

138.56
Delayed Data
As of 4:02pm ET
 -0.96 / -0.69%
Today’s Change
95.37
Today|||52-Week Range
143.22
+22.93%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Operating ActivitiesNet Income / Starting Line230.2M186.1M170.1M-2.8M
 
 
 
 
 
Depreciation21.1M18.9M20.7M21.2M
 
 
 
 
 
Total Other Cash Flow21.3M49.1M-1.1M13.9M
 
 
 
 
 
Funds From Operations309.2M261.2M190.1M6.0M
 
 
 
 
 
Funds From/For Other Operating Expenses180.9M63.5M-120.7M-357.9M
 
 
 
 
 
Net Cash Flow - Operating Activities128.3M197.7M310.8M363.9M
 
 
 
 
 
 
InvestingIncrease In Investments-171.8M-671.9M-359.0M-144.7M
 
 
 
 
 
Decrease In Investments423.0M98.7M192.6M397.4M
 
 
 
 
 
Capital Expenditures-15.9M-58.0M-42.3M-51.9M
 
 
 
 
 
Net Assets From Acquisitions -82.0M-2.8M-100.0K-108.0M
 
 
 
 
 
Other Investing - Sources600.0K-500.0K300.0K400.0K
 
 
 
 
 
Net Cash Flow Investing151.2M-638.2M-209.5M49.3M
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings377.4M608.0M3.9M5.4M
 
 
 
 
 
Long Term Debt Reduction-353.4M-454.8M-4.6M-5.6M
 
 
 
 
 
Net Proceeds Stock Sale23.1M45.6M22.6M22.5M
 
 
 
 
 
Common Preferred Redeemed-437.4M-73.8M-800.0K-251.3M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total0.000.00------
Other Sources - Financing0.00800.0K-800.0K0.00
 
 
 
Other Uses - Financing1.0M----0.00
 
 
Net Cash Flow - Financing-391.3M126.8M20.3M-229.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash1.0M2.6M500.0K3.8M
 
 
 
 
 
 
Net Change In Cash-111.8M-313.7M121.6M184.2M